🇺🇸 FDA
Pipeline program

SALINE, TRANEXAMIC ACID

Approved small_molecule active

Quick answer

SALINE, TRANEXAMIC ACID for Slipped capital femoral epiphysis (SCFE), Legg-Calvé-Perthes Disease (LCPD), Neuromuscular conditions, Secondary hip dysplasia, Developmental dysplasia of the hip (DDH) is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Slipped capital femoral epiphysis (SCFE), Legg-Calvé-Perthes Disease (LCPD), Neuromuscular conditions, Secondary hip dysplasia, Developmental dysplasia of the hip (DDH)
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials